Abstract:Objective: Hepatocellular carcinoma (HCC) is one of the most prevalent types of cancer worldwide. Shugoshin 1 (SGOL1) plays a crucial role in cell mitosis and its aberrant expression level in human tumors has shown to promote chromosomal instability (CIN) and accelerate tumor growth. SGOL1 expression level in HCC cells and tissues, whether it has an influence on HCC patients' prognosis, and its mechanism of action have not yet been studied. Methods: We carried out the bioinformatics analysis of SGOL1 expression level and survival analysis in 8 different malignancies, including HCC. In addition, we analyzed SGOL1 expression level in HCC tissues, as well as HCC patients' clinical features, enrichment analysis of SGOL1 function and mechanism of action in HCC and tumor immune cells. The effects of SGOL1 expression level and cell viability on HCC were confirmed by in vitro cytological assays. Results: It was found that SGOL1 mRNA expression level was significantly higher in several tumor tissues, including HCC, than in corresponding normal tissues, and the elevated SGOL1 expression level was strongly associated with HCC patients' poor prognosis. It was also revealed that SGOL1 expression level in HCC tissue was positively correlated with disease stage, tumor grade, and tumor size, and the results of multivariate logistic regression analysis showed that SGOL1 was one of the independent influential factors of the prognosis of HCC. Enrichment analysis revealed that SGOL1 expression level in HCC tissue was mainly associated with tumor proliferation, cell cycle, and other factors. The results of the immune infiltration analysis indicated that SGOL1 expression level was associated with immune cell infiltration and immune checkpoints in HCC. In vitro experiments demonstrated the high SGOL1 expression level in HCC tissues and cells, and silencing of SGOL1 resulted in altered cell cycle markers and decreased proliferation, invasion, and migration of HCC cells. Conclusion: The findings revealed that SGOL1 is highly expressed in HCC tissues, it is a biomarker of a poor prognosis, which may be related to immune cell infiltration in HCC, and may enhance the proliferation, invasion, and migration of HCC cells. The results may provide new insights into targeted treatment of HCC and improve HCC patients' prognosis.

SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis

196P Expression of Musashi-1 Protein and Its Implications in Progression and Prognosis of Gastric Cancer

SSH1 Promotes Progression of Intrahepatic Cholangiocarcinoma Via P38 MAPK-CXCL8 Axis.

GSE1 Predicts Poor Survival Outcome in Gastric Cancer Patients by SLC7A5 Enhancement of Tumor Growth and Metastasis.

Expression Of Shh Signaling Pathway Factors In Gastrointestinal Stromal Tumor Tissues And Their Associations With Clinical Pathological Factors

Nuclear Expression of Glioma-Associated Oncogene Homolog 1 and Nuclear Factor-κB is Associated with a Poor Prognosis of Pancreatic Cancer

ASF1b is a Novel Prognostic Predictor Associated with Cell Cycle Signaling Pathway in Gastric Cancer

Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach

The prognostic significance of SHP2 and its binding protein Hook1 in non-small cell lung cancer.

The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer

High level of SMN1 in esophageal cancer predicts poor prognosis: An analysis based on TCGA data

Overexpression of Ras-GTPase-activating Protein SH3 Domain-Binding Protein 1 Correlates with Poor Prognosis in Gastric Cancer Patients.

Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients

Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44(+)/Musashi-1(+) gastric cancer stem cells

MGST1 Expression Is Associated with Poor Prognosis, Enhancing the Wnt/β-Catenin Pathway via Regulating AKT and Inhibiting Ferroptosis in Gastric Cancer

Expression of GLS 1 in Intrahepatic Cholangiocarcinoma and Its Clinical Significance

Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma

High Expression of Heat Shock Protein Family D Member 1 Predicts Poor Prognosis of Esophageal Cancer

Identification of key biomarkers and potential signaling pathway associated with poor progression of gastric cancer

High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers

SMU1 Knockdown Suppresses Gastric Carcinoma Growth, Migration, and Invasion and Modulates the Cell Cycle